Can Australia's small cap stocks build on a strong showing in 2025 and positive earnings growth to make next year one to ...

S&P/ASX All Ords Index (ASX: XAO) shares returned 10.56%, including dividends, while the ASX Small Ords Index produced 24.96% ...

The 2025 calendar year delivered a decisive breakout for Australian small caps – can this momentum extend into 2026?

ASX small caps outperformed in 2025, but 2026 is more likely to be a case of picking winners. Here are six reasons why.

ASX small caps outperformed in 2025, but 2026 is more likely to be a case of picking winners. Here are seven (more) reasons ...

The global biotechnology sector is on track to become a multi-trillion dollar industry. Worldwide, the biotech space is worth an estimated US$1.76 trillion this year, according to Grand View Research.

(Reuters) -Long overlooked as the backwater of the Australian equity market, small-cap stocks are having their best run in over a decade due to strong earnings and growth potential, as pricey ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) is down 0.65% on Thursday at 3,139.3 points. ASX small-cap shares represent young and growing companies with a market capitalisation of between a few ...

Investors with a higher than average tolerance for risk might want to check out the small cap ASX stocks in this article.

After the best year for WAM Active since inception 18 years ago, the fund manager cautions that the easy money in small caps ...

The global biotechnology sector is on track to become a multi-trillion dollar industry. Worldwide, the biotech space is worth an estimated US$1.76 trillion this year, according to Grand View Research.